Octreotide doses of 50 – 100 mcg have been shown to reduce average GH levels within a few hours in both healthy adults and acromegaly patients (14, 15), as well as reduction in TSH within 6 – 10 hours among patients with TSH-secreting pituitary adenomas (16, 17). This evidence concerns the gene GH1 and acromegaly.